Literature DB >> 10816503

Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

M Lizotte-Waniewski1, W Tawe, D B Guiliano, W Lu, J Liu, S A Williams, S Lustigman.   

Abstract

The search for appropriate vaccine candidates and drug targets against onchocerciasis has so far been confronted with several limitations due to the unavailability of biological material, appropriate molecular resources, and knowledge of the parasite biology. To identify targets for vaccine or chemotherapy development we have undertaken two approaches. First, cDNA expression libraries were constructed from life cycle stages that are critical for establishment of Onchocerca volvulus infection, the third-stage larvae (L3) and the molting L3. A gene discovery effort was then initiated by random expressed sequence tag analysis of 5,506 cDNA clones. Cluster analyses showed that many of the transcripts were up-regulated and/or stage specific in either one or both of the cDNA libraries when compared to the microfilariae, L2, and both adult stages of the parasite. Homology searches against the GenBank database facilitated the identification of several genes of interest, such as proteinases, proteinase inhibitors, antioxidant or detoxification enzymes, and neurotransmitter receptors, as well as structural and housekeeping genes. Other O. volvulus genes showed homology only to predicted genes from the free-living nematode Caenorhabditis elegans or were entirely novel. Some of the novel proteins contain potential secretory leaders. Secondly, by immunoscreening the molting L3 cDNA library with a pool of human sera from putatively immune individuals, we identified six novel immunogenic proteins that otherwise would not have been identified as potential vaccinogens using the gene discovery effort. This study lays a solid foundation for a better understanding of the biology of O. volvulus as well as for the identification of novel targets for filaricidal agents and/or vaccines against onchocerciasis based on immunological and rational hypothesis-driven research.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816503      PMCID: PMC97634          DOI: 10.1128/IAI.68.6.3491-3501.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  83 in total

1.  Purification of a 44 kilodalton protease which mediates the ecdysis of infective Haemonchus contortus larvae.

Authors:  H R Gamble; J P Purcell; R H Fetterer
Journal:  Mol Biochem Parasitol       Date:  1989-02       Impact factor: 1.759

2.  Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

3.  Cloning and characterization of Ancylostoma-secreted protein. A novel protein associated with the transition to parasitism by infective hookworm larvae.

Authors:  J M Hawdon; B F Jones; D R Hoffman; P J Hotez
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

Review 4.  Caenorhabditis elegans as a model for parasitic nematodes.

Authors:  T R Bürglin; E Lobos; M L Blaxter
Journal:  Int J Parasitol       Date:  1998-03       Impact factor: 3.981

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

6.  Steroid/thyroid hormone receptor genes in Caenorhabditis elegans.

Authors:  Z Kostrouch; M Kostrouchova; J E Rall
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

7.  A survey of genes expressed in adults of the human hookworm, Necator americanus.

Authors:  J Daub; A Loukas; D I Pritchard; M Blaxter
Journal:  Parasitology       Date:  2000-02       Impact factor: 3.234

8.  Molecular cloning and characterization of onchocystatin, a cysteine proteinase inhibitor of Onchocerca volvulus.

Authors:  S Lustigman; B Brotman; T Huima; A M Prince; J H McKerrow
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

9.  A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18.

Authors:  M Moyle; D L Foster; D E McGrath; S M Brown; Y Laroche; J De Meutter; P Stanssens; C A Bogowitz; V A Fried; J A Ely
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

10.  Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals.

Authors:  D J Ward; T B Nutman; G Zea-Flores; C Portocarrero; A Lujan; E A Ottesen
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

View more
  28 in total

1.  Screening the Schistosoma mansoni transcriptome for genes differentially expressed in the schistosomulum stage in search for vaccine candidates.

Authors:  Leonardo P Farias; Cibele A Tararam; Patricia A Miyasato; Milton Y Nishiyama; Katia C Oliveira; Toshie Kawano; Sergio Verjovski-Almeida; Luciana Cezar de Cerqueira Leite
Journal:  Parasitol Res       Date:  2010-09-18       Impact factor: 2.289

Review 2.  Onchocerca volvulus: The Road from Basic Biology to a Vaccine.

Authors:  Sara Lustigman; Benjamin L Makepeace; Thomas R Klei; Simon A Babayan; Peter Hotez; David Abraham; Maria Elena Bottazzi
Journal:  Trends Parasitol       Date:  2017-09-22

3.  Cloning and characterization of a novel immunogenic protein 3 (NIP3) from Brugia malayi by immuno screening of a phage-display cDNA expression library.

Authors:  Munirathinam Gnanasekar; Balumuri Padmavathi; Kalyanasundaram Ramaswamy
Journal:  Parasitol Res       Date:  2005-06-11       Impact factor: 2.289

4.  Exploiting the Polypharmacology of ß-Carbolines to Disrupt O. volvulus Molting.

Authors:  Major Gooyit; Nancy Tricoche; Sacha Javor; Sara Lustigman; Kim D Janda
Journal:  ACS Med Chem Lett       Date:  2015-01-20       Impact factor: 4.345

5.  Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans.

Authors:  James S McCarthy; Moira Wieseman; Joe Tropea; David Kaslow; David Abraham; Sara Lustigman; Rocky Tuan; Ronald H Guderian; Thomas B Nutman
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Screening of different classes of proteases in microfilarial and adult stages of Setaria cervi.

Authors:  Daya Ram Pokharel; Elesela Srikanth; Sushma Rathaur
Journal:  Parasitol Res       Date:  2009-01-29       Impact factor: 2.289

7.  The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.

Authors:  Fidelis Cho-Ngwa; Jing Liu; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2010-08-24

8.  Identification and cloning of a novel tetraspanin (TSP) homologue from Brugia malayi.

Authors:  Munirathinam Gnanasekar; Setty Balakrishnan Anand; Kalyanasundaram Ramaswamy
Journal:  DNA Seq       Date:  2008-04

9.  Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi.

Authors:  S K Verma; I Bansal; S Vedi; J K Saxena; V M Katoch; S M Bhattacharya
Journal:  Parasitol Res       Date:  2007-12-07       Impact factor: 2.289

10.  The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.

Authors:  Thomas Ebensen; Kai Schulze; Peggy Riese; Michael Morr; Carlos A Guzmán
Journal:  Clin Vaccine Immunol       Date:  2007-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.